annual CAPEX:
$523.00M-$62.00M(-10.60%)Summary
- As of today (April 15, 2025), GILD annual capital expenditures is $523.00 million, with the most recent change of -$62.00 million (-10.60%) on December 31, 2024.
- During the last 3 years, GILD annual CAPEX has fallen by -$56.00 million (-9.67%).
- GILD annual CAPEX is now -43.40% below its all-time high of $924.00 million, reached on December 31, 2018.
Performance
GILD CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$147.00M+$6.00M(+4.26%)Summary
- As of today (April 15, 2025), GILD quarterly capital expenditures is $147.00 million, with the most recent change of +$6.00 million (+4.26%) on December 31, 2024.
- Over the past year, GILD quarterly CAPEX has increased by +$6.00 million (+4.26%).
- GILD quarterly CAPEX is now -50.51% below its all-time high of $297.00 million, reached on June 30, 2018.
Performance
GILD quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$523.00M-$68.00M(-11.51%)Summary
- As of today (April 15, 2025), GILD TTM capital expenditures is $523.00 million, with the most recent change of -$68.00 million (-11.51%) on December 31, 2024.
- Over the past year, GILD TTM CAPEX has dropped by -$68.00 million (-11.51%).
- GILD TTM CAPEX is now -44.89% below its all-time high of $949.00 million, reached on March 31, 2019.
Performance
GILD TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
GILD CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.6% | +4.3% | -11.5% |
| 3 y3 years | -9.7% | +4.3% | -11.5% |
| 5 y5 years | -36.6% | +4.3% | -11.5% |
GILD CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -28.2% | at low | -40.5% | +40.0% | -28.2% | at low |
| 5 y | 5-year | -36.6% | at low | -40.5% | +40.0% | -31.1% | at low |
| alltime | all time | -43.4% | >+9999.0% | -50.5% | +274.2% | -44.9% | +1045.8% |
Gilead Sciences CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $523.00M(-10.6%) | $147.00M(+4.3%) | $523.00M(-11.5%) |
| Sep 2024 | - | $141.00M(+8.5%) | $591.00M(+3.3%) |
| Jun 2024 | - | $130.00M(+23.8%) | $572.00M(-1.5%) |
| Mar 2024 | - | $105.00M(-51.2%) | $581.00M(-0.7%) |
| Dec 2023 | $585.00M(-19.6%) | $215.00M(+76.2%) | $585.00M(+6.2%) |
| Sep 2023 | - | $122.00M(-12.2%) | $551.00M(-6.0%) |
| Jun 2023 | - | $139.00M(+27.5%) | $586.00M(-0.7%) |
| Mar 2023 | - | $109.00M(-39.8%) | $590.00M(-19.0%) |
| Dec 2022 | $728.00M(+25.7%) | $181.00M(+15.3%) | $728.00M(+3.6%) |
| Sep 2022 | - | $157.00M(+9.8%) | $703.00M(+2.6%) |
| Jun 2022 | - | $143.00M(-42.1%) | $685.00M(+3.6%) |
| Mar 2022 | - | $247.00M(+58.3%) | $661.00M(+14.2%) |
| Dec 2021 | $579.00M(-10.9%) | $156.00M(+12.2%) | $579.00M(-4.1%) |
| Sep 2021 | - | $139.00M(+16.8%) | $604.00M(-2.6%) |
| Jun 2021 | - | $119.00M(-27.9%) | $620.00M(-3.7%) |
| Mar 2021 | - | $165.00M(-8.8%) | $644.00M(-0.9%) |
| Dec 2020 | $650.00M(-21.2%) | $181.00M(+16.8%) | $650.00M(-3.3%) |
| Sep 2020 | - | $155.00M(+8.4%) | $672.00M(-6.3%) |
| Jun 2020 | - | $143.00M(-16.4%) | $717.00M(-5.5%) |
| Mar 2020 | - | $171.00M(-15.8%) | $759.00M(-8.0%) |
| Dec 2019 | $825.00M(-10.7%) | $203.00M(+1.5%) | $825.00M(-5.2%) |
| Sep 2019 | - | $200.00M(+8.1%) | $870.00M(+3.9%) |
| Jun 2019 | - | $185.00M(-21.9%) | $837.00M(-11.8%) |
| Mar 2019 | - | $237.00M(-4.4%) | $949.00M(+2.7%) |
| Dec 2018 | $924.00M(+56.6%) | $248.00M(+48.5%) | $924.00M(+3.1%) |
| Sep 2018 | - | $167.00M(-43.8%) | $896.00M(+4.4%) |
| Jun 2018 | - | $297.00M(+40.1%) | $858.00M(+25.4%) |
| Mar 2018 | - | $212.00M(-3.6%) | $684.00M(+15.9%) |
| Dec 2017 | $590.00M(-21.1%) | $220.00M(+70.5%) | $590.00M(+9.5%) |
| Sep 2017 | - | $129.00M(+4.9%) | $539.00M(-11.3%) |
| Jun 2017 | - | $123.00M(+4.2%) | $608.00M(-11.8%) |
| Mar 2017 | - | $118.00M(-30.2%) | $689.00M(-7.9%) |
| Dec 2016 | $748.00M(+0.1%) | $169.00M(-14.6%) | $748.00M(+0.4%) |
| Sep 2016 | - | $198.00M(-2.9%) | $745.00M(-10.6%) |
| Jun 2016 | - | $204.00M(+15.3%) | $833.00M(+4.1%) |
| Mar 2016 | - | $177.00M(+6.6%) | $800.00M(+7.1%) |
| Dec 2015 | $747.00M(+34.1%) | $166.00M(-42.0%) | $747.00M(-0.1%) |
| Sep 2015 | - | $286.00M(+67.3%) | $748.00M(+25.3%) |
| Jun 2015 | - | $171.00M(+37.9%) | $597.00M(+15.5%) |
| Mar 2015 | - | $124.00M(-25.7%) | $517.00M(-7.2%) |
| Dec 2014 | $557.00M(+193.2%) | $167.00M(+23.7%) | $557.00M(+21.4%) |
| Sep 2014 | - | $135.00M(+48.4%) | $458.69M(+27.1%) |
| Jun 2014 | - | $91.00M(-44.5%) | $360.87M(+14.5%) |
| Mar 2014 | - | $164.00M(+138.8%) | $315.15M(+65.9%) |
| Dec 2013 | $190.00M(-52.1%) | $68.69M(+84.7%) | $190.00M(-51.4%) |
| Sep 2013 | - | $37.18M(-17.9%) | $391.13M(-7.0%) |
| Jun 2013 | - | $45.28M(+16.5%) | $420.54M(+1.9%) |
| Mar 2013 | - | $38.85M(-85.6%) | $412.65M(+3.9%) |
| Dec 2012 | $397.00M(+201.0%) | $269.82M(+305.2%) | $397.00M(+159.0%) |
| Sep 2012 | - | $66.58M(+78.1%) | $153.28M(+1.5%) |
| Jun 2012 | - | $37.39M(+61.2%) | $150.99M(+7.7%) |
| Mar 2012 | - | $23.20M(-11.1%) | $140.23M(+6.3%) |
| Dec 2011 | $131.90M(+113.1%) | $26.11M(-59.4%) | $131.90M(+2.1%) |
| Sep 2011 | - | $64.29M(+141.4%) | $129.16M(+70.7%) |
| Jun 2011 | - | $26.64M(+79.1%) | $75.67M(+16.3%) |
| Mar 2011 | - | $14.87M(-36.3%) | $65.09M(+5.2%) |
| Dec 2010 | $61.88M(-73.1%) | $23.36M(+116.2%) | $61.88M(-5.5%) |
| Sep 2010 | - | $10.81M(-32.7%) | $65.51M(-10.0%) |
| Jun 2010 | - | $16.05M(+37.6%) | $72.83M(-6.2%) |
| Mar 2010 | - | $11.67M(-56.8%) | $77.65M(-66.2%) |
| Dec 2009 | $230.06M(+100.0%) | $26.99M(+48.9%) | $230.06M(-6.0%) |
| Sep 2009 | - | $18.13M(-13.2%) | $244.73M(-5.1%) |
| Jun 2009 | - | $20.87M(-87.3%) | $258.00M(-1.6%) |
| Mar 2009 | - | $164.07M(+293.8%) | $262.33M(+128.1%) |
| Dec 2008 | $115.00M | $41.66M(+32.7%) | $115.00M(+24.1%) |
| Sep 2008 | - | $31.40M(+24.6%) | $92.67M(+25.6%) |
| Jun 2008 | - | $25.20M(+50.4%) | $73.77M(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $16.75M(-13.3%) | $70.36M(-10.5%) |
| Dec 2007 | $78.65M(-25.2%) | $19.32M(+54.6%) | $78.65M(-12.2%) |
| Sep 2007 | - | $12.50M(-42.6%) | $89.54M(-24.4%) |
| Jun 2007 | - | $21.79M(-13.0%) | $118.45M(+2.1%) |
| Mar 2007 | - | $25.04M(-17.1%) | $115.99M(+10.2%) |
| Dec 2006 | $105.21M(+119.4%) | $30.21M(-27.0%) | $105.21M(+19.5%) |
| Sep 2006 | - | $41.41M(+114.3%) | $88.04M(+52.0%) |
| Jun 2006 | - | $19.33M(+35.5%) | $57.91M(+8.6%) |
| Mar 2006 | - | $14.26M(+9.3%) | $53.33M(+11.2%) |
| Dec 2005 | $47.95M(-6.6%) | $13.04M(+15.6%) | $47.95M(-16.1%) |
| Sep 2005 | - | $11.29M(-23.5%) | $57.18M(+0.7%) |
| Jun 2005 | - | $14.75M(+66.2%) | $56.79M(+3.5%) |
| Mar 2005 | - | $8.88M(-60.1%) | $54.89M(+6.9%) |
| Dec 2004 | $51.37M(+33.0%) | $22.27M(+104.3%) | $51.37M(-192.9%) |
| Sep 2004 | - | $10.90M(-15.1%) | -$55.30M(-212.9%) |
| Jun 2004 | - | $12.84M(+139.8%) | $48.99M(+18.6%) |
| Mar 2004 | - | $5.36M(-106.3%) | $41.29M(+7.0%) |
| Dec 2003 | $38.61M(+119.4%) | -$84.39M(-173.3%) | $38.61M(-69.9%) |
| Sep 2003 | - | $115.19M(+2139.7%) | $128.07M(+647.3%) |
| Jun 2003 | - | $5.14M(+92.6%) | $17.14M(-0.6%) |
| Mar 2003 | - | $2.67M(-47.4%) | $17.24M(-2.0%) |
| Dec 2002 | $17.60M(-33.2%) | $5.08M(+19.4%) | $17.60M(-20.7%) |
| Sep 2002 | - | $4.25M(-18.9%) | $22.19M(-5.8%) |
| Jun 2002 | - | $5.24M(+73.0%) | $23.57M(-9.7%) |
| Mar 2002 | - | $3.03M(-68.7%) | $26.11M(-0.9%) |
| Dec 2001 | $26.33M(+68.6%) | $9.67M(+72.0%) | $26.33M(+27.2%) |
| Sep 2001 | - | $5.62M(-27.8%) | $20.70M(+0.1%) |
| Jun 2001 | - | $7.78M(+139.2%) | $20.68M(+36.5%) |
| Mar 2001 | - | $3.25M(-19.6%) | $15.15M(-3.0%) |
| Dec 2000 | $15.62M(+25.0%) | $4.05M(-27.8%) | $15.62M(-6.3%) |
| Sep 2000 | - | $5.60M(+149.1%) | $16.68M(+30.9%) |
| Jun 2000 | - | $2.25M(-39.6%) | $12.74M(+1.8%) |
| Mar 2000 | - | $3.72M(-27.0%) | $12.51M(+0.1%) |
| Dec 1999 | $12.50M(+13.6%) | $5.10M(+206.5%) | $12.50M(+28.9%) |
| Sep 1999 | - | $1.66M(-17.7%) | $9.70M(-38.0%) |
| Jun 1999 | - | $2.02M(-45.6%) | $15.64M(+12.4%) |
| Mar 1999 | - | $3.71M(+61.5%) | $13.91M(+26.5%) |
| Dec 1998 | $11.00M(-20.3%) | $2.30M(-69.7%) | $11.00M(-43.3%) |
| Sep 1998 | - | $7.60M(+2433.3%) | $19.40M(+59.0%) |
| Jun 1998 | - | $300.00K(-62.5%) | $12.20M(-4.7%) |
| Mar 1998 | - | $800.00K(-92.5%) | $12.80M(-7.2%) |
| Dec 1997 | $13.80M(+273.0%) | $10.70M(+2575.0%) | $13.80M(+165.4%) |
| Sep 1997 | - | $400.00K(-55.6%) | $5.20M(-1.9%) |
| Jun 1997 | - | $900.00K(-50.0%) | $5.30M(+3.9%) |
| Mar 1997 | - | $1.80M(-14.3%) | $5.10M(+37.8%) |
| Dec 1996 | $3.70M(+516.7%) | $2.10M(+320.0%) | $3.70M(+131.3%) |
| Sep 1996 | - | $500.00K(-28.6%) | $1.60M(+23.1%) |
| Jun 1996 | - | $700.00K(+75.0%) | $1.30M(+85.7%) |
| Mar 1996 | - | $400.00K(+100.0%) | $700.00K(-61.1%) |
| Dec 1995 | $600.00K(-84.6%) | - | - |
| Sep 1995 | - | $200.00K(+100.0%) | $1.80M(-51.4%) |
| Jun 1995 | - | $100.00K(-50.0%) | $3.70M(-5.1%) |
| Mar 1995 | - | $200.00K(-84.6%) | $3.90M(-2.5%) |
| Mar 1995 | $3.90M(+21.9%) | - | - |
| Dec 1994 | - | $1.30M(-38.1%) | $4.00M(+29.0%) |
| Sep 1994 | - | $2.10M(+600.0%) | $3.10M(+34.8%) |
| Jun 1994 | - | $300.00K(0.0%) | $2.30M(-28.1%) |
| Mar 1994 | $3.20M(-27.3%) | $300.00K(-25.0%) | $3.20M(-46.7%) |
| Dec 1993 | - | $400.00K(-69.2%) | $6.00M(-6.3%) |
| Sep 1993 | - | $1.30M(+8.3%) | $6.40M(+20.8%) |
| Jun 1993 | - | $1.20M(-61.3%) | $5.30M(+20.5%) |
| Mar 1993 | $4.40M(+780.0%) | $3.10M(+287.5%) | $4.40M(+238.5%) |
| Dec 1992 | - | $800.00K(+300.0%) | $1.30M(+160.0%) |
| Sep 1992 | - | $200.00K(-33.3%) | $500.00K(+66.7%) |
| Jun 1992 | - | $300.00K | $300.00K |
| Mar 1992 | $500.00K(+66.7%) | - | - |
| Mar 1991 | $300.00K | - | - |
FAQ
- What is Gilead Sciences annual capital expenditures?
- What is the all time high annual CAPEX for Gilead Sciences?
- What is Gilead Sciences annual CAPEX year-on-year change?
- What is Gilead Sciences quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Gilead Sciences?
- What is Gilead Sciences quarterly CAPEX year-on-year change?
- What is Gilead Sciences TTM capital expenditures?
- What is the all time high TTM CAPEX for Gilead Sciences?
- What is Gilead Sciences TTM CAPEX year-on-year change?
What is Gilead Sciences annual capital expenditures?
The current annual CAPEX of GILD is $523.00M
What is the all time high annual CAPEX for Gilead Sciences?
Gilead Sciences all-time high annual capital expenditures is $924.00M
What is Gilead Sciences annual CAPEX year-on-year change?
Over the past year, GILD annual capital expenditures has changed by -$62.00M (-10.60%)
What is Gilead Sciences quarterly capital expenditures?
The current quarterly CAPEX of GILD is $147.00M
What is the all time high quarterly CAPEX for Gilead Sciences?
Gilead Sciences all-time high quarterly capital expenditures is $297.00M
What is Gilead Sciences quarterly CAPEX year-on-year change?
Over the past year, GILD quarterly capital expenditures has changed by +$6.00M (+4.26%)
What is Gilead Sciences TTM capital expenditures?
The current TTM CAPEX of GILD is $523.00M
What is the all time high TTM CAPEX for Gilead Sciences?
Gilead Sciences all-time high TTM capital expenditures is $949.00M
What is Gilead Sciences TTM CAPEX year-on-year change?
Over the past year, GILD TTM capital expenditures has changed by -$68.00M (-11.51%)